top of page

Medical Board of Advisors 2022-2024

Cristina P. Rodriguez, MD - (Seattle WA) – Dr. Rodriquez is a Physician at Seattle Cancer Care Alliance and Associate Professor, Division of Medical Oncology University of Washington School of Medicine, Associate Professor, Clinical Research Division Fred Hutchinson Cancer Research Center specializes in treating patients with head and neck cancer and salivary gland cancer. Dr. Rodriquez's expertise also includes treating thyroid and lung cancers. While there have been significant advances in the prevention, detection, and treatment of these diseases, there are certain ethnic and demographic groups who continue to experience poor outcomes. These groups tend to have limited access to care and may experience exposure to risk factors — such as tobacco, alcohol, and human papillomavirus (HPV) infections — that can contribute to cancer. Her hope is that disparities in cancer care will be alleviated in her life through public awareness and collaborative efforts between the scientific community and health policymakers.

Don S. Dizon, MD, FACP, FASCO(Providence, RI) – Dr. Dizon is the Head of Women’s Cancers at Lifespan Cancer Institute, Director of Medical Oncology at Rhode Island Hospital, and Associate Professor of Medicine at The Warren Alpert Medical School of Brown University in Providence, RI (USA). He was trained in medical oncology at Memorial Sloan-Kettering Cancer Center (MSKCC) where he was also on the faculty in the Developmental Therapeutics section and Gynecologic Oncology Disease Management Team at MSKCC until 2003. Between 2003 and 2009 he was the director of medical oncology at the Program in Women's Oncology at Women & Infants Hospital of Rhode Island where he also founded the Center for Sexuality, Intimacy, and Fertility for women with cancer (CSIF)- the first program of its kind in Rhode Island. In July 2012, he transferred his clinical practice to MGH, where he founded and directed the Oncology Sexual Health Clinic at the MGH Cancer Center. Between 2014 and 2017 he was the Clinical Co-Director of Gynecologic Oncology at the MGH Cancer Center. In addition to his clinical duties, he is a co-chair of the Cervical Cancer Task Force for the NCI Gynecologic Cancer Steering Committee, section editor in Gynecologic Oncology at UpToDate, and serves on multiple editorial boards, including for The Oncologist, the Journal of Clinical Oncology, and the American Journal of Clinical Oncology. He is also prolific on social media and maintains online columns at Connection and for the journal, The Oncologist.  He chairs the Digital Engagement Committee for SWOG, a member of the NCI National Clinical Trials Network. In 2018, he was named a Fellow of the American Society of Clinical Oncology. Dr. Dizon is on Instagram and on Twitter as @drdonsdizon.

Dr. Clieto Reyes-Gibby (Houston TX) – Dr. Reyes-Gibby is an Associate Professor in the Department of Emergency Medicine and Associate Professor in the Department of Biostatistics at the University of Texas MD Anderson Cancer Center. She is also an Adjunct Associate Professor at The University of Texas School of Public Health. Dr. Reyes-Gibby is a population-based scientist, and the focus of her research is on the application of classical and molecular epidemiology approaches to understanding the complex interaction among clinical, epidemiological, and biological/genetic factors on the occurrence and persistence of cancer-related symptoms and toxicities of cancer treatment. She is the 2016 recipient of the Provost Distinguished Faculty Mentor Award at MD Anderson.

Dr. Emilia Diego (Pittsburgh, PA) – Dr. Diego is an Assistant Professor of Surgery, University of Pittsburgh School of Medicine Section Chief, Breast Surgical Oncology Program Director, Breast Surgical Oncology Fellowship Director, Pre-Menopausal Breast Cancer Program. Dr. Emilia Diego received her medical degree from the University of the Philippines College of Medicine, Manila, Philippines. She completed a residency in general surgery at Mercy Catholic Medical Center in Darby, Pa., and a surgical breast oncology fellowship at UPMC. Dr. Diego is board-certified in surgery and specializes in premenopausal breast cancer, breast conservation therapy, locally advanced breast cancer, and high-risk breast disease. Dr. Diego is a member of the Society of Surgical Oncology, American Society of Breast Surgery, American Society of Clinical Oncology, American College of Surgeons, and the Association of Women Surgeons.

Dr. Elwyn Cabebe (Palo Alto, CA) – Dr. Cabebe is s a general medical oncologist and hematologist. He is the Director of Oncology Quality for the Stanford University HealthCare Alliance. He specializes and is board certified in oncology, hematology, internal medicine, and hospice and palliative care. As a community leader in general oncology and hematology with over 10 years in private practice, Dr. Cabebe is inspired by his patients’ continuous rise to the challenge of fighting illness and the constant re-defining of “normal.” He strives to provide truthful and compassionate care as well as developing a partnership of shared decision making with his patients. He recognizes that cancer is an uninvited, life-altering condition. He feels that his role for patients and their families is to shepherd them through the difficult process of a cancer diagnosis and treatment with the focus on maintaining the best quality of life possible. Prior to medical school, Dr. Cabebe was a research associate at Genentech, Inc., helping to develop many of the modern cancer drugs used today. During his fellowship at Stanford Medicine, Dr. Cabebe served as a clinical instructor and conducted various phase clinical trials in solid tumors with emphasis on gastrointestinal malignancies, pancreatic and colorectal cancers, as well as early phase I trials with the Experimental Therapeutics Program. He also served as Adjunct Clinical Faculty after fellowship. Dr. Cabebe holds various medical directorship roles including Medical Director of Oncology and Chair of the Cancer Committee at Good Samaritan Hospital in Los Gatos, California. He was also the past Medical Director for Clinical Research at El Camino Hospital in Mountain View, California. Dr. Cabebe serves as Expert Medical Reviewer for the California Medical Board as well as an author for various cancer reviews on WebMD and Medscape.

Dr. Marlon Saria (Los Angeles, CA) – Dr. Saria is an advanced practice registered nurse serving in multiple roles ranging from direct clinical care to program development and management. His program of research is grounded on two overlapping themes- the effect of cancer- and cancer-related toxicities on patient outcomes and the impact of caregiver burden on caregiver well-being outcomes, patient health outcomes, and healthcare utilization outcomes. Dr. Saria serves in the U.S. Air Force Reserve as a flight commander in the aerospace medical squadron. He was inducted as a Fellow of the American Academy of Nursing in 2014.

Edwin M. Posadas, MD, FACP, (Los Angeles, CA) - Dr. Posadas is the Director of the Translational Oncology Program and the Medical Director of the Urologic Oncology Program at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center. He has both clinical and research interests in the treatment of advanced prostate cancer and the biology of cancer metastasis. Posadas is studying the mechanisms through which cancer cells in localized tumors spread to other parts of the body. A protein called FYN, a member of a cancer-causing gene family was identified in his laboratory as a possible regulator of metastasis and the neuroendocrine phenotype of prostate cancer. Additionally, his laboratory has been studying the role of circulating tumor cells (CTCs) and immune cells (ICs) as biomarkers in prostate and other cancers using novel nanotechnology platforms. His current research interests focus on the most aggressive subtypes of prostate cancer that spread to organs such as the liver and lungs. At Cedars-Sinai, Dr. Posadas is working to define the function of FYN, CTCs, and ICs in prostate cancer, with the goal of applying his basic science findings to the development of new therapies and diagnostic tools that will directly benefit men with advanced prostate cancer. Clinically, he specializes in the use of medical therapies for prostate, kidney, bladder, and testis cancer with an emphasis on integrated, trans-disciplinary care.  Languages Spoken English / Filipino / French / Italian / Thai. Education: Medical School: Johns Hopkins School of Medicine, 1998 Residency: University of Michigan Medical School, 2001 Fellowship: National Cancer Institute, 2005. 

Richelle B. Miller, DNP, AGNP-BC, and MBA (Tempe, AZ) - Richelle is a Bone Marrow Transplant Nurse Practitioner at Banner MD Anderson Cancer Center which is ranked # 1 Cancer Center in the world.  Richelle has been instrumental in spreading the Asian American Stem Cell and Organ Donor Program in the State of Arizona.  She is a member of various professional organizations such as the American Society for Transplantation and Cellular Therapy, the American Academy of Nurse Practitioners, the Philippine Nurses Association of Arizona East Valley, and Gerontological Advanced Practice Nurses Association.  Richelle has been traveled and explored more than 90 countries and speaks multiple languages such as English, Tagalog, Hiligaynon, Spanish, French, German, and Arabic.

bottom of page